Our readers will remember this post by Suchita which apart from a highly memorable picture from Shrek, also dealt with the important issue of profit margins in terms of pharmaceutical manufacture. And now, SpicyIP is thrilled to report to its readers that there is finally a down to earth, honest admission by an Indian entrepreneur on the state of Global health care, and India’s contribution or lack thereof to it.
The article revolves around the current health policy across the globe and India’s particular susceptibility to be slotted into the category of a State with a particularly “ineffectual” health policy.
Given this background, Ms. Mazumdar Shaw in her short punchy piece has put in her two cents. Stressing on the need to be more of a leader, than an imitator, this article seems to take the initiative in finding the much desired “middle path” and balancing competing interests of innovation with the costs spent in drug discovery, experimentation and so forth.
The article does not provide a solution- that, of course, would have been a near impossibility given that most companies engaged in pharmaceutical manufature have vastly differing philosophies. However, the piece does stress the need to create the concept of “affordable innovation” to help aid the global health crises, and leaves the modalities of the same open ended. Which is much food for thought.
